The novel coronavirus disease 2019 (COVID-19) pandemic has seen many drugs being repositioned or repurposed for the treatment of COVID-19. Among the repurposed drugs, azithromycin has caught the limelight, where it is frequently administered to patients with COVID-19 alongside chloroquine or hydroxychloroquine.
|Number of pages||2|
|Journal||Clinical Drug Investigation|
|Early online date||20 Aug 2020|
|Publication status||Published - 1 Oct 2020|